Welltower (NYSE:WELL – Get Free Report) had its price target raised by research analysts at Bank of America from $190.00 to $221.00 in a research report issued to clients and investors on Friday,Benzinga reports. The firm currently has a “buy” rating on the real estate investment trust’s stock. Bank of America‘s target price suggests a potential upside of 61.29% from the company’s current price.
Several other equities research analysts have also commented on WELL. Scotiabank boosted their price objective on shares of Welltower from $133.00 to $142.00 and gave the stock a “sector outperform” rating in a research report on Monday, November 25th. Raymond James lifted their price target on Welltower from $145.00 to $155.00 and gave the company a “strong-buy” rating in a report on Monday, December 16th. StockNews.com raised Welltower from a “sell” rating to a “hold” rating in a research report on Wednesday, October 30th. Wells Fargo & Company restated an “equal weight” rating and set a $135.00 target price (up previously from $134.00) on shares of Welltower in a report on Tuesday, October 1st. Finally, Mizuho lifted their price objective on shares of Welltower from $136.00 to $141.00 and gave the company an “outperform” rating in a research note on Thursday, December 5th. Five analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $134.81.
Check Out Our Latest Report on WELL
Welltower Stock Up 3.6 %
Welltower (NYSE:WELL – Get Free Report) last issued its quarterly earnings data on Monday, October 28th. The real estate investment trust reported $0.73 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.04 by ($0.31). Welltower had a return on equity of 3.20% and a net margin of 12.22%. The business had revenue of $2.06 billion for the quarter, compared to analysts’ expectations of $1.95 billion. During the same period in the previous year, the business posted $0.92 earnings per share. The company’s revenue for the quarter was up 23.7% on a year-over-year basis. On average, equities analysts forecast that Welltower will post 4.3 earnings per share for the current year.
Institutional Investors Weigh In On Welltower
A number of large investors have recently added to or reduced their stakes in the stock. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in shares of Welltower by 638.0% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 6,920,426 shares of the real estate investment trust’s stock worth $886,022,000 after purchasing an additional 5,982,711 shares during the last quarter. FMR LLC raised its stake in shares of Welltower by 38.1% in the third quarter. FMR LLC now owns 14,428,564 shares of the real estate investment trust’s stock valued at $1,847,289,000 after purchasing an additional 3,977,845 shares in the last quarter. Duff & Phelps Investment Management Co. bought a new position in shares of Welltower during the 2nd quarter worth about $254,977,000. Wellington Management Group LLP boosted its holdings in Welltower by 10.6% during the third quarter. Wellington Management Group LLP now owns 18,685,844 shares of the real estate investment trust’s stock valued at $2,392,349,000 after purchasing an additional 1,797,330 shares in the last quarter. Finally, Barclays PLC grew its position in Welltower by 29.2% in the third quarter. Barclays PLC now owns 1,684,446 shares of the real estate investment trust’s stock valued at $215,659,000 after acquiring an additional 380,888 shares during the period. Institutional investors own 94.80% of the company’s stock.
About Welltower
Welltower Inc (NYSE:WELL), a real estate investment trust (“REIT”) and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience.
Featured Articles
- Five stocks we like better than Welltower
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- Top Stocks Investing in 5G Technology
- 3 Buy-and-Hold Stocks for Long-Term Growth
- How to Effectively Use the MarketBeat Ratings Screener
- Despite Short-Term Risks Freeport McMoran Worth a Look
Receive News & Ratings for Welltower Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Welltower and related companies with MarketBeat.com's FREE daily email newsletter.